Biotrial
Expertise Partner
Biotrial is a scientifically oriented clinical research organization with 35+ years of experience managing preclinical and clinical CNS studies. The company is comprised of a global team of 350+ employees and physical locations in the US, EU, UK, and Canada. Fully in-house, Biotrial offers In-vivo safety & pharmacology, Patient Clinical trials support and Phase I facilities, as well as Core Lab, Biometrics, and Bioanalytical services for biotech and pharma companies. Biotrial expertise in CNS biomarkers -- EEG & qEEG assessments, ERP, PSG, sleep studies, video-oculography, and various cognitive tests is especially strong.
Centre for Human Drug Research (CHDR)
Program Partner
The Centre for Human Drug Research (CHDR) is an independent institute that specialises in cutting-edge early-stage clinical drug research. Combining innovative methods and technologies, state-of-the-art facilities, and talented, motivated researchers helps CHDR maximise their clients’ success. In addition, CHDR places the highest priority on their subjects’ comfort and safety, and they play an active role in helping educate the medical and clinical research communities.
Bit.bio
Innovation Partner
bit.bio is a synthetic biology company focused on human cells that is advancing medicine and enabling curative treatments. bit.bio’s opti-ox™ precision cell programming technology enables conversion of induced pluripotent stem cells (iPSCs) into any desired human cell type in a single step, at industrial scale, while maintaining exceptional purity and consistency. The ioCells™ research cell product portfolio is opening up new possibilities for studying human biology and developing new medicines in research and drug discovery.
Eurofins BioPharma Product Testing
Innovation Partner
Eurofins BioPharma Product Testing (BPT) delivers a broad range of harmonized methodologies under GMP authorization and certification. We offer R&D services for method development of analytical methods suitable for GMP Chemistry and Microbiology testing and certification of raw materials and finished products. Our 30,000 ft2 laboratory is equipped with state of the art analytical instrumentation and includes a sterility suite, a wide array of stability chambers as well as an extensive controlled drug substance license and narcotics vault.
Sama Therapeutics
Event Partner
Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The company's agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing "software as medical device" for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We invite partners to join our mission unlocking brain health through integrative neurotechnology and proven “transprognostic” algorithms.
SynapCell
Event Partner
SynapCell is a leader in preclinical efficacy testing in CNS disorders, supporting international biopharmaceutical companies in identifying their most promising candidates. The translational, objective EEG endpoints we have characterize in translational animal models in vivo have enabled our clients to unlock the true potential of their drugs. Our areas of expertise span from epilepsy to neuropsychiatry and movement disorders. We strongly believe that regular back-and-forth interactions with Sponsor throughout the project is the key to make the most out of an experiment and deliver clear, comprehensive information to help our clients decide on a GO/NO GO decision towards the clinic.
Advanced Brain Monitoring
Event Partner
Advanced Brain Monitoring is a pioneer in brain health. ABM provided comprehensive EEG services for over 50 clinical trials and research projects where we acquired and curated an expansive EEG database, developed proprietary algorithms and validated unique biomarkers associated with cognitive decline in diseases such as MCI, Alzheimer’s, Lewy Body, Parkinson’s, and psychiatric diseases such as depression and anxiety.
ABM’s platform, including our FDA-cleared, mobile, wireless EEG/ECG device, provides objective, quantitative profiles of neural activity during resting state, attention, memory and sensory tasks. EEG endpoints can be quantified in reference to our normative data or in comparison to patients with neurological and psychiatric disorders.
ABM provides technology and know-how for all phases of clinical trials worldwide. Our team can assist sponsors in translational efforts including identification of EEG biomarkers of target engagement and selecting and optimizing doses. Our large reference datasets offer the potential for adding age and sex matched healthy controls to any clinical trial.
www.advancedbrainmonitoring.com/services/clinical-trials
